echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Peptide News > Pathogenesis of hypertrophic cardiomyopathy was found

    Pathogenesis of hypertrophic cardiomyopathy was found

    • Last Update: 2014-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Hypertrophic cardiomyopathy is one of the most common cardiovascular and cerebrovascular diseases Japan's Keio University announced in a communique Tuesday that the team had found substances that worsened the condition Hypertrophic cardiomyopathy is caused by the thickening of the heart muscle, which makes it difficult to deliver blood to the whole body Sometimes it will lead to heart failure, which is one of the causes of sudden exercise death Researchers at Keio University used somatic cells from patients with severe hypertrophic cardiomyopathy and healthy people to create iPS cells and then cardiomyocytes It is found that the myofibrils are arranged orderly in the heart cells of healthy people, but the arrangement of myofibrils in the heart cells of patients with hypertrophic cardiomyopathy is very disordered, and the contraction of the heart cells is also abnormal When the researchers further analyzed the factors that led to the deterioration, they found that a substance called endothelin-1 significantly increased the confusion of myofibril arrangement Endothelin-1 is a hormone produced when the heart bears the load due to exercise It not only exists in vascular endothelium, but also widely exists in various tissues and cells It is an important factor in regulating cardiovascular function and plays an important role in maintaining basic vascular tension At the same time, it was found that a drug called endothelin vasoconstrictor receptor antagonist could improve the disorder of myofibril arrangement and contraction of cardiomyocytes The drug has been used to treat pulmonary hypertension, and its safety to human body has been confirmed.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.